Results 151 to 160 of about 45,438 (256)
Epidemiology of Spinal Muscular Atrophy in Iceland: A Population-Based Study.
Mainka Sveindóttir AS +3 more
europepmc +1 more source
Spinal muscular atrophy type I in a 3.5-month-old male infant: A case report. [PDF]
Nawaz RN +5 more
europepmc +1 more source
ABSTRACT Background Testosterone deficiency is highly prevalent in men with chronic spinal cord injury (SCI) and is associated with obesity, sarcopenia, systemic inflammation, and metabolic dysfunction. However, the independent prognostic role of low testosterone in long‐term mortality in this population remains unclear.
D. Tienforti +8 more
wiley +1 more source
Lung Function and Respiratory Muscle Strength in Symptomatic Children and Adults With Spinal Muscular Atrophy Treated With Nusinersen. [PDF]
Vercoelen F +13 more
europepmc +1 more source
ABSTRACT Background Paediatric neuromuscular and syndromic scoliosis patients have multiple medical comorbidities that increase the risk of postoperative complications. There is a lack of consistent literature assessing the specific risk factors for complications following scoliosis correction surgery in this high‐risk cohort.
Mai Pham +4 more
wiley +1 more source
Treatment evolution in spinal muscular atrophy: insights from the SMArtCARE registry. [PDF]
Voigt-Müller C +12 more
europepmc +1 more source
The Swedish National Pediatric Cataract Register (PECARE): Coexisting systemic disorders 2007–2023
Abstract Purpose To analyse the frequency and type of coexisting systemic disorders in children operated on for cataract in Sweden. Methods Data were retrieved from the Swedish National Pediatric Cataract Register (PECARE) for children operated between January 1, 2007, and December 31, 2023 (n = 975), including follow‐ups at age 1, 2, 5 and 10 ...
David Wackerberg +9 more
wiley +1 more source
KIF5A downregulation in spinal muscular atrophy links axonal regeneration defects with ALS. [PDF]
Akiyama T +16 more
europepmc +1 more source
Untargeted multiomic profiling of cerebrospinal fluid reveals that proteomic, but not lipidomic, signatures robustly distinguish ALS patients from controls and stratify individuals by survival, highlighting marked molecular differences between short survival and long survival disease.
Sergio Roca‐Pereira +19 more
wiley +1 more source

